Knowledge

Cockayne syndrome

Source đź“ť

593:
clear-cut, and some researchers believe the signs and symptoms reflect a spectrum instead of distinct types: Cockayne syndrome Type A (CSA) is marked by normal development until a child is 1 or 2 years old, at which point growth slows and developmental delays are noticed. Symptoms are not apparent until they are 1 year. Life expectancy for type A is approximately 10 to 20 years. These symptoms are seen in CS type 1 children. Cockayne syndrome type B (CSB), also known as "cerebro-oculo-facio-skeletal (COFS) syndrome" (or "Pena-Shokeir syndrome type B"), is the most severe subtype. Symptoms are present at birth and normal brain development stops after birth. The average lifespan for children with type B is up to 7 years of age. These symptoms are seen in CS type 2 children. Cockayne syndrome type C (CSC) appears later in childhood with milder symptoms than the other types and a slower progression of the disorder. People with this type of Cockayne syndrome live into adulthood, with an average lifespan of 40 to 50 years. These symptoms are seen in CS type 3.
392:, particularly the DNA in active genes. DNA damage is caused by ultraviolet rays from sunlight, radiation, or free radicals in the body. A normal cell can repair DNA damage before it accumulates. If either the ERCC6 or the ERCC8 gene is altered (as in Cockayne Syndrome), DNA damage encountered during transcription isn't repaired, causing RNA polymerase to stall at that location, interfering with gene expression. As the unrepaired DNA damage accumulates, progressively more active gene expression is impeded, leading to malfunctioning cells or cell death, which likely contributes to the signs of Cockayne Syndrome such as premature aging and neuronal hypomyelination. 201:) and is much more severe than CS Type 1. It involves very little neurological development after birth. Death usually occurs by age seven. This specific type has also been designated as cerebro-oculo-facio-skeletal (COFS) syndrome or Pena-Shokeir syndrome Type II. COFS syndrome is named so due to the effects it has on the brain, eyes, face, and skeletal system, as the disease frequently causes brain atrophy, cataracts, loss of fat in the face, and osteoporosis. COFS syndrome can be further subdivided into several conditions (COFS types 1, 2, 3 (associated with 289:. The resulting accumulation of oxidative damage could impair the normal functions of the DNA and may even result in triggering a program of cell death (apoptosis). The children with this disease do not repair the active genes where oxidative damage occurs. Normally, oxidative damage repair is faster in the active genes (which make up less than five percent of the genome) than in inactive regions of the DNA. The resulting accumulation of oxidative damage could impair the normal functions of the DNA and may even result in triggering a program of cell death ( 86: 576:
Syndrome patients are very sensitive to UV radiation. Optimal nutrition can also help. Genetic counseling for the parents is recommended, as the disorder has a 25% chance of being passed to any future children, and prenatal testing is also a possibility. Another important aspect is the prevention of recurrence of CS in other siblings. Identification of gene defects involved makes it possible to offer genetic counseling and antenatal diagnostic testing to the parents who already have one affected child.
59: 180:(1880–1956) who first described it in 1936 and re-described in 1946. Neill-Dingwall syndrome was named after Mary M. Dingwall and Catherine A. Neill. These two scientists described the case of two brothers with Cockayne syndrome and asserted it was the same disease described by Cockayne. In their article, the two contributed to the signs of the disease through their discovery of calcifications in the brain. They also compared Cockayne syndrome to what is now known as 302: 285:. Each lesion—a damaged section of DNA—must be snipped out and the DNA repaired to preserve its normal function. Unrepaired DNA can lose its ability to code for proteins. Mutations also can result. These mutations can activate oncogenes or silence tumor suppressor genes. According to research, oxidative damage to active genes is not preferentially repaired, and in the most severe cases, the repair is slowed throughout the whole 510:, or involuntary eye movement, and pupils that fail to dilate demonstrate a loss of control of voluntary and involuntary muscle movement. A salt and pepper retinal pigmentation is also a typical sign. Diagnosis is determined by a specific test for DNA repair, which measures the recovery of RNA after exposure to UV radiation. Despite being associated with genes involved in 431:, particularly inter-strand cross-links, double-strand breaks and some monoadducts. CSB protein is also normally recruited to DNA damaged sites, and its recruitment is most rapid and robust as follows: interstrand crosslinks > double-strand breaks > monoadducts > oxidative damage. CSB protein forms a complex with another DNA repair protein, SNM1A ( 502:), and serious sensitivity to sunlight are common, even in individuals without XP-CS. Often patients with Cockayne Syndrome will severely burn or blister with very little heat exposure. The eyes of patients can be affected in various ways and eye abnormalities are common in CS. Cataracts and cloudiness of the cornea ( 601:
Cockayne syndrome is rare worldwide. No racial predilection is reported for Cockayne syndrome. No sexual predilection is described for Cockayne syndrome; the male-to-female ratio is equal. Cockayne syndrome I (CS-A) manifests in childhood. Cockayne syndrome II (CS-B) manifests at birth or in infancy,
211:
Xeroderma pigmentosum-Cockayne syndrome (XP-CS) occurs when an individual also has xeroderma pigmentosum, another DNA repair disease. Some symptoms of each disease are expressed. For instance, freckling and pigment abnormalities characteristic of XP are present. The neurological disorder, spasticity,
579:
Currently, there are two ongoing projects focused on the development of gene therapy for Cockayne syndrome. The first project, led by the Viljem Julijan Association for Children with Rare Diseases, aims to develop gene therapy specifically for Cockayne syndrome type B. The second project, led by the
575:
There is no permanent cure for this syndrome, although patients can be symptomatically treated. Treatment usually involves physical therapy and minor surgeries to the affected organs, such as cataract removal. Also wearing high-factor sunscreen and protective clothing is recommended because Cockayne
592:
for those with Cockayne syndrome is poor, as death typically occurs by the age of 12. The prognosis for Cockayne syndrome varies by disease type. There are three types of Cockayne syndrome according to the severity and onset of the symptoms. However, the differences between the types are not always
172:
mechanism. Unlike other defects of DNA repair, patients with CS are not predisposed to cancer or infection. Cockayne syndrome is a rare but destructive disease usually resulting in death within the first or second decade of life. The mutation of specific genes in Cockayne syndrome is known, but the
193:
CS Type I, the "classic" form, is characterized by normal fetal growth with the onset of abnormalities in the first two years of life. Vision and hearing gradually decline. The central and peripheral nervous systems progressively degenerate until death in the first or second decade of life as a
610:
The recent research on Jan 2018 mentions different CS features that are seen globally with similarities and differences: CS has an incidence of 1 in 250,000 live births, and a prevalence of approximately 1 per 2.5 million, which is remarkably consistent across various regions globally:
387:
Mutations in the ERCC8 (also known as CSA) gene or the ERCC6 (also known as CSB) gene are the cause of Cockayne syndrome type A and type B. Mutations in the ERCC6 gene mutation makes up ~70% of cases. The proteins made by these genes are involved in repairing damaged DNA via the
136:
and neurological disorders are criteria for diagnosis, while photosensitivity, hearing loss, eye abnormalities, and cavities are other very common features. Problems with any or all of the internal organs are possible. It is associated with a group of disorders called
498:), due to a loss of subcutaneous fat. Their small chin, large ears, and pointy, thin nose often give an aged appearance. The skin of those with Cockayne syndrome is also frequently affected: hyperpigmentation, varicose or spider veins ( 530:
Laboratory studies are mainly useful to eliminate other disorders. For example, skeletal radiography, endocrinologic tests, and chromosomal breakage studies can help in excluding disorders included in the differential diagnosis.
205:) and 4). Typically patients with this early-onset form of the disorder show more severe brain damage, including reduced myelination of white matter, and more widespread calcifications, including in the cortex and basal ganglia. 439:, that localizes to inter-strand cross-links in a transcription dependent manner. The accumulation of CSB protein at sites of DNA double-strand breaks occurs in a transcription dependent manner and facilitates 2356: 2336: 1486:
Bender M, Potocki L, Metry D. What syndrome is this? Cockayne syndrome. Pediatric Dermatology . November 2003;20(6):538-540. Available from: MEDLINE with Full Text, Ipswich, MA. Accessed April 30, 2015.
2962: 555:
Imaging studies reveal a widespread absence of the myelin sheaths of the neurons in the white matter of the brain and general atrophy of the cortex. Calcifications have also been found in the
1700:
Laugel V. Cockayne Syndrome. 2000 Dec 28 . In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® . Seattle (WA): University of Washington, Seattle; 1993-2015. Available from:
2955: 2495: 3448: 2128:
Title: Cockayne Syndrome Authors: Dr Nita R Sutay, Dr Md Ashfaque Tinmaswala, Dr Manjiri Karlekar, Dr Swati Jhahttp://jmscr.igmpublication.org/v3-i7/35%20jmscr.pdf
3403: 2948: 2246:
Kubota, Masaya; Ohta, Sayaka; Ando, Aki; Koyama, Akiko; Terashima, Hiroshi; Kashii, Hirofumi; Hoshino, Hideki; Sugita, Katsuo; Hayashi, Masaharu (June 2015).
212:
and underdevelopment of sexual organs characteristic of CS are seen. However, hypomyelination and the facial features of typical CS patients are not present.
547:
Prenatal evaluation is possible. Amniotic fluid cell culturing is used to demonstrate that fetal cells are deficient in RNA synthesis after UV irradiation.
1737:
Vessoni, Alexandre Teixeira; Guerra, Camila Chaves Coelho; Kajitani, Gustavo Satoru; Nascimento, Livia Luz Souza; Garcia, Camila CarriĂŁo Machado (2020).
3390: 17: 567:
found in patients with Cockayne syndrome could also result in the lack of muscle control, particularly involuntary, and poor posture typically seen.
2113: 3438: 811: 2488: 3220: 389: 301: 208:
CS Type III, characterized by late-onset, is typically milder than Types I and II. Often patients with Type III will live into adulthood.
3458: 3096: 2744: 2481: 1634:
Neill CA, Dingwall MM. A Syndrome Resembling Progeria: A Review of Two Cases. Archives of Disease in Childhood. 1950;25(123):213-223.
563:
that regulates movements and aids in some forms of learning, along with the cortex. Additionally, atrophy of the central area of the
181: 3423: 2551: 2546: 1462: 902:
may be grossly deformed ("cactus flowers"), ferruginated dendrites. Dendrites have fewer higher order branches. Purkinje "
2371: 2940: 2646: 2248:"Nationwide survey of Cockayne syndrome in Japan: Incidence, clinical course and prognosis: Cockayne syndrome in Japan" 3213: 3003: 2759: 2684: 3350: 3183: 3057: 2784: 428: 2053:"DNA damage during the G0/G1 phase triggers RNA-templated, Cockayne syndrome B-dependent homologous recombination" 3433: 3106: 2749: 420:. This deficiency reflects the loss of ability to perform the DNA repair process known as transcription coupled 241:. In normal cells, our body repairs the damaged sections. In the case of this disease, due to subtle defects in 2979: 2846: 3264: 3162: 2694: 3453: 3206: 2754: 2651: 2541: 721: 2971: 2874: 2666: 2636: 1311: 580:
Riaan Research Initiative, is dedicated to the development of gene therapy for Cockayne syndrome type A.
506:) are common. The loss of and damage to the nerves of the optic nerve, causing optic atrophy, can occur. 2461: 2293: 2110: 3355: 3345: 3274: 3129: 3084: 3045: 2810: 2709: 2616: 2606: 2561: 963: 511: 467: 421: 2004:"Cockayne syndrome group B protein regulates DNA double-strand break repair and checkpoint activation" 451:
of the cell cycle, DNA damage can trigger a CSB-dependent recombinational repair process that uses an
3124: 2805: 2689: 1363: 1192: 32: 2183: 3335: 3178: 2764: 2601: 2513: 2388: 1454: 440: 269:
involving oxygen can generate several highly reactive free radicals. These free radicals can cause
85: 859:. Relative sparing of the cerebral cortex, slight thinning of cortical ribbon may be seen. Normal 3443: 3101: 2674: 2184:"Cockayne syndrome | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program" 1404:
Bertola; Cao, H; Albano, Lm; Oliveira, Dp; Kok, F; Marques-Dias, Mj; Kim, Ca; Hegele, Ra (2006).
1182: 922: 768: 414: 242: 539:
Brain CT scanning in Cockayne syndrome patients may reveal calcifications and cortical atrophy.
253:
needed by the body does not operate at normal capacity. Over time, went this theory, results in
3428: 3365: 3319: 3024: 2679: 2504: 2109:
Kyllermen, Marten. Cockayne Syndrome. Swedish Information Centre for Rare Diseases. 2012: 4.0.
1303: 1155: 1104: 1060: 1027: 933: 674: 177: 3370: 3287: 3067: 2913: 2901: 2885: 2857: 2581: 2521: 1145: 1018: 515: 202: 2197:
Karikkineth, A. C.; Scheibye-Knudsen, M.; Fivenson, E.; Croteau, D. L.; Bohr, V. A. (2016).
1739:"Cockayne Syndrome: The many challenges and approaches to understand a multifaceted disease" 1446: 462:
The premature aging features of CS are likely due, at least in part, to the deficiencies in
2869: 2853: 2841: 2829: 2064: 1953:
Iyama T, Lee SY, Berquist BR, Gileadi O, Bohr VA, Seidman MM, McHugh PJ, Wilson DM (2015).
1906:"Elements That Regulate the DNA Damage Response of Proteins Defective in Cockayne Syndrome" 1712: 1373: 527: 486:), their eyes appear sunken, and they have an "aged" look. They often have long limbs with 184:(HGPS), then called progeria, due to the advanced aging that characterizes both disorders. 8: 3340: 3292: 3229: 3166: 3088: 2970: 2736: 2724: 2360: 1796:"Deficient repair of the transcribed strand of active genes in Cockayne's syndrome cells" 1447: 1248: 1001: 764: 711: 526:
In Cockayne syndrome patients, UV-irradiated cells show decreased DNA and RNA synthesis.
306: 230: 194:
result of serious neurological degradation. Cortical atrophy is less severe in CS Type I.
2068: 2571: 2531: 2275: 2223: 2198: 2087: 2052: 2028: 2003: 1979: 1954: 1930: 1905: 1878: 1853: 1771: 1738: 1533: 1088: 1046: 1005: 997: 950: 910: 826: 691: 683: 487: 2365: 1820: 1795: 1794:
van Hoffen A, Natarajan AT, Mayne LV, van Zeeland AA, Mullenders LH, Venema J (1993).
257:
failure and death. Every minute, the body pumps 10 to 20 liters of oxygen through the
173:
widespread effects and its relationship with DNA repair is yet to be well understood.
3380: 3375: 2834: 2621: 2536: 2399: 2267: 2228: 2092: 2033: 1984: 1935: 1883: 1825: 1776: 1758: 1678:
Javadzadeh M. Cockayne Syndrome. Iran J Child Neurol. Autumn 2014;8;4(Suppl.1):18-19.
1655: 1610: 1568: 1525: 1517: 1458: 1427: 1297: 982: 752: 638: 133: 113: 66: 2139: 1754: 1537: 2918: 2894: 2774: 2769: 2631: 2576: 2473: 2279: 2259: 2218: 2210: 2082: 2072: 2051:
Wei L, Nakajima S, Böhm S, Bernstein KA, Shen Z, Tsang M, Levine AS, Lan L (2015).
2023: 2015: 1974: 1966: 1925: 1917: 1873: 1865: 1815: 1807: 1766: 1750: 1602: 1560: 1509: 1417: 1378: 1240: 1199: 1174: 660: 413:
induced by the action of ultraviolet (UV) light on the template strand of actively
410: 282: 270: 138: 125: 71: 2439: 3254: 3157: 2987: 2975: 2906: 2890: 2878: 2862: 2789: 2656: 2641: 2626: 2393: 2117: 1852:
Karikkineth A, Scheibye-Knudsen M, Fivenson E, Croteau D, Bohr B (January 2017).
1383: 1321: 1170: 978: 918: 891: 822: 777: 740: 725: 503: 129: 3360: 3259: 3173: 3152: 3074: 2927: 2779: 2526: 1368: 1346: 1307: 1239:
show changes in advanced atherosclerosis and arteriolosclerosis. Unilateral or
1236: 1159: 1128: 899: 883: 875: 815: 663:. Wrinkled and aged appearing skin. Thin dry hair, prematurely gray hair. Poor 655: 499: 117: 2450: 2404: 2345: 2214: 1921: 1869: 1701: 1513: 1422: 1405: 3417: 3385: 3246: 3146: 3062: 2593: 1811: 1762: 1593:
Nance M, Berry S (1 January 1992). "Cockayne syndrome: review of 140 cases".
1521: 1325: 1315: 1231: 1211: 1096: 1013: 986: 974: 926: 872: 856: 785: 773: 729: 717: 634: 254: 234: 2077: 2019: 1955:"CSB interacts with SNM1A and promotes DNA interstrand crosslink processing" 1606: 1497: 58: 2699: 2271: 2232: 2096: 2037: 1988: 1939: 1887: 1780: 1687:
Cerebrooculofacioskeletal Syndrome 2. Online Mendelian Inheritance in Man.
1572: 1529: 1431: 1226: 1207: 1203: 1196: 1151: 1116: 1068: 1042: 959: 848: 736: 679: 479: 402: 142: 2196: 1970: 1851: 1829: 1614: 1564: 3116: 2719: 2445: 2247: 1444: 1338: 1134: 1092: 1080: 801: 748: 436: 310: 79: 814:, especially in areas of Metachromatic leukodystrophy, calcification in 633:
Wizened faceies. Sunken eyes, large ears, thin pointy nose. Small chin.
427:
Within the damaged cell, the CSA protein normally localizes to sites of
3237: 3036: 3013: 2714: 1342: 1268: 1264: 1215: 1076: 1064: 1038: 836: 819: 797: 760: 564: 463: 274: 266: 237:. This can cause oxidative damage to cellular components including the 198: 169: 3198: 2328: 2263: 1847: 1845: 1843: 1841: 1839: 116:
disorder characterized by growth failure, impaired development of the
2434: 2410: 2111:
http://www.socialstyrelsen.se/rarediseases/cockaynesyndrome#anchor_17
1658:
Published April 28, 2015. Reviewed May 2010. Accessed April 30, 2015.
1406:"Cockayne syndrome type A: novel mutations in eight typical patients" 1286: 1124: 1109: 1023: 956: 930: 906: 895: 868: 852: 844: 840: 744: 589: 560: 507: 290: 262: 222: 110: 107: 75: 1087:
and outer nuclear cell layers. Both the outer and inner segments of
141:, which are conditions characterized by degradation of neurological 3314: 3018: 2997: 2703: 2566: 2456: 1836: 1793: 1498:"Cockayne syndrome: the expanding clinical and mutational spectrum" 1403: 1137: 1120: 1112: 1084: 914: 807: 793: 789: 756: 703: 495: 491: 483: 448: 444: 246: 121: 2199:"Cockayne syndrome: Clinical features, model systems and pathways" 1854:"Cockayne syndrome: Clinical features, model systems and pathways" 2415: 1332: 1282: 1057: 1054: 970: 946: 887: 879: 830: 707: 556: 432: 250: 28: 2382: 2379: 2376: 1688: 1551:
Hoeijmakers JH (October 2009). "DNA damage, aging, and cancer".
409:
deficient cells are unable to preferentially repair cyclobutane
375: 359: 343: 261:, carrying it to billions of cells in our bodies. In its normal 2340: 2001: 1736: 1188: 1166: 1072: 1034: 1031: 993: 990: 903: 699: 695: 687: 664: 478:
People with this syndrome have smaller than normal head sizes (
286: 278: 226: 281:
occur in the DNA every day. Many of these lesions result from
2163: 937: 864: 860: 781: 733: 406: 364: 348: 258: 161: 151: 490:(inability to relax the muscle at a joint), a hunched back ( 3306: 2349: 651: 647: 628: 417: 330: 318: 2002:
Batenburg NL, Thompson EL, Hendrickson EA, Zhu XD (2015).
1000:. Loss of hair cells in pars superior. Loss of neurons in 27:"Cocaine syndrome" redirects here. For the substance, see 2312: 518:, CS is not associated with an increased risk of cancer. 456: 452: 238: 2050: 528:
https://emedicine.medscape.com/article/1115866-workup#c5
273:
to cellular components including the DNA. In an average
233:
produces several highly reactive forms of oxygen called
2311:
This article incorporates some public domain text from
2140:"Cockayne syndrome type b | Viljem Julijan Association" 1952: 1386:— thought to be a form (or subset) of Cockayne syndrome 1445:
James, William; Berger, Timothy; Elston, Dirk (2005).
867:. Lamination, neuronal size, and configuration of the 1026:. Usually bilateral, most develop by 4 years of age. 2503: 2318: 2245: 401:
In contrast to cells with normal repair capability,
145:. There are two primary types of Cockayne syndrome: 1449:
Andrews' Diseases of the Skin: Clinical Dermatology
1656:http://ghr.nlm.nih.gov/condition/cockayne-syndrome 851:. May be seen as a high-intensity white matter on 3415: 966:(44%) Most commonly bilateral, rarely unilateral 3449:DNA replication and repair-deficiency disorders 2164:"Riaan Research Initiative — Cockayne Syndrome" 1899: 1897: 3404:DNA replication and repair-deficiency disorder 1550: 3214: 2956: 2489: 2044: 1995: 1946: 1894: 1674: 1672: 1670: 1668: 1666: 1664: 300: 265:form, oxygen is harmless. However, cellular 1903: 1787: 1654:Cockayne Syndrome. Genetics Home Reference 1067:deposition, large pigment laden cells in a 3391:Marfanoid–progeroid–lipodystrophy syndrome 3221: 3207: 2963: 2949: 2496: 2482: 1592: 84: 3097:Hereditary nonpolyposis colorectal cancer 2222: 2086: 2076: 2027: 1978: 1929: 1877: 1819: 1770: 1661: 1421: 168:The underlying disorder is a defect in a 1482: 1480: 1478: 1476: 1474: 3228: 1630: 1628: 1626: 1624: 1588: 1586: 1584: 1582: 759:loss at multiple sites, especially the 14: 3439:Syndromes affecting the nervous system 3416: 1495: 390:transcription-coupled repair mechanism 3202: 2944: 2477: 2313:The U.S. National Library of Medicine 2137: 1650: 1648: 1646: 1644: 1642: 1640: 1471: 767:due to anterograde and/or retrograde 521: 3315:Hutchinson–Gilford progeria syndrome 1717:The Lecturio Medical Concept Library 1621: 1595:American Journal of Medical Genetics 1579: 1502:Mechanisms of Ageing and Development 182:Hutchinson–Gilford progeria syndrome 176:It is named after English physician 2144:Cure for Cockayne Syndrome – type B 1453:(10th ed.). Saunders. p.  890:, and in some cases neurons in the 24: 1637: 855:sequences signals. No major brain 605: 534: 443:repair of the breaks. During the 197:CS Type II is present from birth ( 159:, resulting from mutations in the 25: 18:Cerebrooculofacioskeletal syndrome 3470: 2745:Bannayan–Riley–Ruvalcaba syndrome 2304: 3459:Diseases named after discoverers 3184:Severe combined immunodeficiency 317:Cockayne syndrome is classified 149:, arising from mutations in the 57: 3107:Mismatch repair cancer syndrome 2286: 2239: 2190: 2176: 2156: 2131: 2122: 2103: 1755:10.1590/1678-4685-GMB-2019-0085 1730: 1705: 1694: 1681: 596: 2980:DNA repair-deficiency disorder 2552:Bonnet–Dechaume–Blanc syndrome 1743:Genetics and Molecular Biology 1544: 1489: 1438: 1397: 602:and it has a worse prognosis. 542: 494:), and they may be very thin ( 157:Cockayne syndrome type B (CSB) 147:Cockayne syndrome type A (CSA) 13: 1: 3424:Autosomal recessive disorders 2547:Sakati–Nyhan–Tisdale syndrome 1689:https://omim.org/entry/610756 1390: 878:dominance. Severe cerebellar 3351:DeSanctis–Cacchione syndrome 3058:DeSanctis–Cacchione syndrome 3004:Aicardi–Goutières syndrome 4 2785:Tatton-Brown–Rahman syndrome 2755:Benign symmetric lipomatosis 2057:Proc. Natl. Acad. Sci. U.S.A 929:not commonly seen, although 722:Metachromatic leukodystrophy 720:– is patchy and segmental– " 682:usually beginning at age 2. 583: 570: 550: 473: 396: 7: 2875:Branchio-oto-renal syndrome 2750:Beckwith–Wiedemann syndrome 2294:"Orphanet: CAMFAK syndrome" 1904:Iyama T, Wilson DM (2016). 1357: 1312:thyroid-stimulating hormone 1099:, axonal loss, and gliosis 296: 249:machinery for synthesizing 10: 3475: 3356:Nijmegen breakage syndrome 3130:Nijmegen breakage syndrome 3046:Nucleotide excision repair 2847:Zimmermann–Laband syndrome 2799:Laurence–Moon–Bardet–Biedl 2760:Klippel–TrĂ©naunay syndrome 2710:Caudal regression syndrome 2685:Klippel–TrĂ©naunay syndrome 2647:Smith–Lemli–Opitz syndrome 2617:Cornelia de Lange syndrome 969:Loss of hair cells in the 964:sensorineural hearing loss 512:nucleotide excision repair 468:DNA damage theory of aging 441:homologous recombinational 422:nucleotide excision repair 120:, abnormal sensitivity to 26: 3399: 3328: 3305: 3273: 3265:Rothmund–Thomson syndrome 3245: 3236: 3163:Rothmund–Thomson syndrome 3138: 3115: 3083: 3044: 3035: 2986: 2819: 2798: 2735: 2695:Rubinstein–Taybi syndrome 2665: 2592: 2512: 2425: 2322: 2215:10.1016/j.arr.2016.08.002 1922:10.1016/j.jmb.2015.11.020 1870:10.1016/j.arr.2016.08.002 1749:(1 suppl. 1): e20190085. 1514:10.1016/j.mad.2013.02.006 1423:10.1007/s10038-006-0011-7 1410:Journal of Human Genetics 1364:Accelerated aging disease 1193:gastrointestinal motility 863:pattern with widening of 482:), are of short stature ( 305:Cockayne syndrome has an 216: 65: 56: 48: 43: 33:Cockayne (disambiguation) 2765:Neurofibromatosis type I 2652:Snyder–Robinson syndrome 2602:1q21.1 deletion syndrome 2542:Saethre–Chotzen syndrome 2252:Pediatrics International 1496:Laugel, Vincent (2013). 871:are preserved. May show 229:occurs in the body, the 187: 3329:Other/related disorders 2995:Separation/initiation: 2675:Adducted thumb syndrome 2637:Silver–Russell syndrome 2203:Ageing Research Reviews 2078:10.1073/pnas.1507105112 2020:10.15252/embj.201490041 1858:Ageing Research Reviews 1713:"Cell Injury and Death" 1607:10.1002/ajmg.1320420115 1183:Gastrointestinal system 962:. Mixed conductive and 923:neurofibrillary tangles 104:Neill-Dingwall syndrome 52:Neill-Dingwall syndrome 3434:Neurological disorders 3366:Dyskeratosis congenita 3346:Baller–Gerold syndrome 3320:Restrictive dermopathy 3275:NER protein-associated 3025:Dyskeratosis congenita 2811:Laurence–Moon syndrome 2607:Aarskog–Scott syndrome 2562:Baller–Gerold syndrome 2505:Congenital abnormality 1812:10.1093/nar/21.25.5890 1691:. Published 2/12/2007. 1304:sexual characteristics 1285:atrophy. A successful 1156:Aortic root dilatation 1105:Musculoskeletal system 1095:atrophy, with partial 1028:Pigmentary retinopathy 973:, particularly in the 913:enlargement, enlarged 780:(especially depths of 732:are affected. Affects 675:Central nervous system 314: 178:Edward Alfred Cockayne 106:, is a rare and fatal 31:. For other uses, see 3371:Ataxia telangiectasia 3288:Xeroderma pigmentosum 3125:Ataxia–telangiectasia 3068:Xeroderma pigmentosum 2806:Bardet–Biedl syndrome 2690:Nail–patella syndrome 2582:Pierre Robin sequence 2522:Acrocephalosyndactyly 1565:10.1056/NEJMra0804615 1146:Cardiovascular system 1030:("salt and pepper"). 1019:Corneal opacification 977:. Loss of neurons in 516:xeroderma pigmentosum 304: 203:xeroderma pigmentosum 128:), eye disorders and 3336:Li–Fraumeni syndrome 3179:Li–Fraumeni syndrome 2737:Overgrowth syndromes 2138:admin (2020-10-23). 1374:Degenerative disease 712:subdural hemorrhages 3454:Progeroid syndromes 3341:Rapadilino syndrome 3293:Trichothiodystrophy 3230:Progeroid syndromes 3167:RAPADILINO syndrome 3102:Muir–Torre syndrome 3089:DNA mismatch repair 2725:VACTERL association 2069:2015PNAS..112E3495W 1971:10.1093/nar/gku1279 1339:production of sweat 1249:Reproductive system 1241:hypoplastic kidneys 1169:medial thickening. 1127:. Stooped posture. 1083:. Loss of cells in 1002:vestibular ganglion 843:may show irregular 765:anterior horn cells 307:autosomal recessive 277:, several thousand 231:cellular metabolism 2680:Holt–Oram syndrome 2572:Goldenhar syndrome 2532:Carpenter syndrome 2426:External resources 2116:2015-09-24 at the 1289:has been reported. 1047:palpebral fissures 1006:endolymphatic duct 1004:. Collapse of the 951:vestibular systems 909:" may be present. 827:arteriolosclerosis 692:Delayed milestones 684:Mental retardation 522:Laboratory Studies 488:joint contractures 367:(also called CSB) 351:(also called CSA) 315: 3411: 3410: 3381:PIBI(D)S syndrome 3376:De Barsy syndrome 3301: 3300: 3283:Cockayne syndrome 3196: 3195: 3192: 3191: 3054:Cockayne syndrome 2972:Metabolic disease 2938: 2937: 2835:Feingold syndrome 2622:Dubowitz syndrome 2612:Cockayne syndrome 2537:Pfeiffer syndrome 2471: 2470: 2451:Cockayne Syndrome 2264:10.1111/ped.12635 2063:(27): E3495–504. 1959:Nucleic Acids Res 1800:Nucleic Acids Res 1464:978-0-7216-2921-6 1355: 1354: 1302:Normal secondary 1298:Endocrine systems 1200:gastrostomy tubes 1140:, disuse atrophy 1008:of pars inferior 983:auditory pathways 753:peripheral nerves 639:enamel hypoplasia 620:Clinical features 559:, an area of the 411:pyrimidine dimers 384: 383: 134:Failure to thrive 114:neurodegenerative 96:Cockayne syndrome 93: 92: 44:Cockayne syndrome 38:Medical condition 16:(Redirected from 3466: 3243: 3242: 3223: 3216: 3209: 3200: 3199: 3042: 3041: 2965: 2958: 2951: 2942: 2941: 2919:Donohue syndrome 2895:Timothy syndrome 2775:Proteus syndrome 2770:Perlman syndrome 2632:Robinow syndrome 2577:Moebius syndrome 2498: 2491: 2484: 2475: 2474: 2320: 2319: 2298: 2297: 2290: 2284: 2283: 2243: 2237: 2236: 2226: 2194: 2188: 2187: 2180: 2174: 2173: 2171: 2170: 2160: 2154: 2153: 2151: 2150: 2135: 2129: 2126: 2120: 2107: 2101: 2100: 2090: 2080: 2048: 2042: 2041: 2031: 2014:(10): 1399–416. 1999: 1993: 1992: 1982: 1950: 1944: 1943: 1933: 1901: 1892: 1891: 1881: 1849: 1834: 1833: 1823: 1791: 1785: 1784: 1774: 1734: 1728: 1727: 1725: 1723: 1709: 1703: 1698: 1692: 1685: 1679: 1676: 1659: 1652: 1635: 1632: 1619: 1618: 1590: 1577: 1576: 1548: 1542: 1541: 1508:(5–6): 161–170. 1493: 1487: 1484: 1469: 1468: 1452: 1442: 1436: 1435: 1425: 1401: 1379:Genetic disorder 1175:arteriosclerosis 917:magna are seen. 661:Photosensitivity 614: 613: 324: 323: 283:oxidative damage 271:oxidative damage 139:leukodystrophies 126:photosensitivity 89: 88: 72:Medical genetics 61: 41: 40: 21: 3474: 3473: 3469: 3468: 3467: 3465: 3464: 3463: 3414: 3413: 3412: 3407: 3395: 3324: 3297: 3269: 3255:Werner syndrome 3247:RecQ-associated 3232: 3227: 3197: 3188: 3158:Werner syndrome 3134: 3111: 3079: 3031: 2988:DNA replication 2982: 2976:DNA replication 2969: 2939: 2934: 2907:Marfan syndrome 2891:Keutel syndrome 2879:CHARGE syndrome 2863:Fraser syndrome 2821: 2820:Combined/other, 2815: 2794: 2790:Weaver syndrome 2731: 2661: 2657:Turner syndrome 2642:Seckel syndrome 2627:Noonan syndrome 2588: 2508: 2502: 2472: 2467: 2466: 2421: 2420: 2331: 2307: 2302: 2301: 2292: 2291: 2287: 2244: 2240: 2195: 2191: 2182: 2181: 2177: 2168: 2166: 2162: 2161: 2157: 2148: 2146: 2136: 2132: 2127: 2123: 2118:Wayback Machine 2108: 2104: 2049: 2045: 2000: 1996: 1951: 1947: 1902: 1895: 1850: 1837: 1792: 1788: 1735: 1731: 1721: 1719: 1711: 1710: 1706: 1699: 1695: 1686: 1682: 1677: 1662: 1653: 1638: 1633: 1622: 1591: 1580: 1559:(15): 1475–85. 1553:N. Engl. J. Med 1549: 1545: 1494: 1490: 1485: 1472: 1465: 1443: 1439: 1402: 1398: 1393: 1384:CAMFAK syndrome 1360: 1333:Eccrine systems 1322:pituitary gland 1171:Atherosclerosis 1053:Patchy loss of 979:spiral ganglion 955:Sensorineural, 919:Amyloid plaques 892:dentate nucleus 823:atherosclerosis 778:cerebral cortex 741:corpus callosum 726:oligodendroglia 608: 606:Recent research 599: 586: 573: 553: 545: 537: 535:Imaging Studies 524: 504:corneal opacity 476: 399: 299: 219: 190: 130:premature aging 102:), also called 83: 39: 36: 23: 22: 15: 12: 11: 5: 3472: 3462: 3461: 3456: 3451: 3446: 3444:Genodermatoses 3441: 3436: 3431: 3426: 3409: 3408: 3400: 3397: 3396: 3394: 3393: 3388: 3383: 3378: 3373: 3368: 3363: 3361:Fanconi anemia 3358: 3353: 3348: 3343: 3338: 3332: 3330: 3326: 3325: 3323: 3322: 3317: 3311: 3309: 3303: 3302: 3299: 3298: 3296: 3295: 3290: 3285: 3279: 3277: 3271: 3270: 3268: 3267: 3262: 3260:Bloom syndrome 3257: 3251: 3249: 3240: 3234: 3233: 3226: 3225: 3218: 3211: 3203: 3194: 3193: 3190: 3189: 3187: 3186: 3181: 3176: 3174:Fanconi anemia 3171: 3170: 3169: 3160: 3155: 3153:Bloom syndrome 3142: 3140: 3136: 3135: 3133: 3132: 3127: 3121: 3119: 3113: 3112: 3110: 3109: 3104: 3099: 3093: 3091: 3081: 3080: 3078: 3077: 3075:IBIDS syndrome 3072: 3071: 3070: 3060: 3050: 3048: 3039: 3033: 3032: 3030: 3029: 3028: 3027: 3009: 3008: 3007: 3006: 2992: 2990: 2984: 2983: 2968: 2967: 2960: 2953: 2945: 2936: 2935: 2933: 2932: 2931: 2930: 2928:Fryns syndrome 2922: 2910: 2898: 2882: 2866: 2850: 2838: 2825: 2823: 2817: 2816: 2814: 2813: 2808: 2802: 2800: 2796: 2795: 2793: 2792: 2787: 2782: 2780:Sotos syndrome 2777: 2772: 2767: 2762: 2757: 2752: 2747: 2741: 2739: 2733: 2732: 2730: 2729: 2728: 2727: 2722: 2717: 2712: 2697: 2692: 2687: 2682: 2677: 2671: 2669: 2663: 2662: 2660: 2659: 2654: 2649: 2644: 2639: 2634: 2629: 2624: 2619: 2614: 2609: 2604: 2598: 2596: 2590: 2589: 2587: 2586: 2585: 2584: 2579: 2574: 2569: 2564: 2556: 2555: 2554: 2549: 2544: 2539: 2534: 2529: 2527:Apert syndrome 2518: 2516: 2510: 2509: 2501: 2500: 2493: 2486: 2478: 2469: 2468: 2465: 2464: 2453: 2442: 2430: 2429: 2427: 2423: 2422: 2419: 2418: 2407: 2396: 2385: 2368: 2353: 2332: 2327: 2326: 2324: 2323:Classification 2317: 2316: 2306: 2305:External links 2303: 2300: 2299: 2285: 2258:(3): 339–347. 2238: 2189: 2175: 2155: 2130: 2121: 2102: 2043: 1994: 1945: 1893: 1835: 1806:(25): 5890–5. 1786: 1729: 1704: 1693: 1680: 1660: 1636: 1620: 1578: 1543: 1488: 1470: 1463: 1437: 1395: 1394: 1392: 1389: 1388: 1387: 1381: 1376: 1371: 1369:Biogerontology 1366: 1359: 1356: 1353: 1352: 1349: 1335: 1329: 1328: 1318: 1316:calcium levels 1308:growth hormone 1300: 1294: 1293: 1290: 1280: 1276: 1275: 1272: 1262: 1258: 1257: 1254: 1251: 1245: 1244: 1237:Renal arteries 1234: 1229: 1223: 1222: 1219: 1185: 1179: 1178: 1163: 1160:Cardiomyopathy 1148: 1142: 1141: 1132: 1129:Muscle wasting 1107: 1101: 1100: 1091:are affected. 1089:photoreceptors 1071:distribution. 1051: 1016: 1010: 1009: 987:Scala communis 967: 953: 943: 942: 900:Purkinje cells 816:leptomeningeal 812:String vessels 792:; also of the 788:, cerebellum, 715: 677: 671: 670: 668: 658: 644: 643: 641: 631: 625: 624: 621: 618: 617:Affected parts 607: 604: 598: 595: 585: 582: 572: 569: 552: 549: 544: 541: 536: 533: 523: 520: 514:(NER), unlike 500:telangiectasia 475: 472: 398: 395: 394: 393: 382: 381: 378: 373: 369: 368: 362: 357: 353: 352: 346: 341: 337: 336: 333: 328: 298: 295: 218: 215: 214: 213: 209: 206: 195: 189: 186: 118:nervous system 91: 90: 69: 63: 62: 54: 53: 50: 46: 45: 37: 9: 6: 4: 3: 2: 3471: 3460: 3457: 3455: 3452: 3450: 3447: 3445: 3442: 3440: 3437: 3435: 3432: 3430: 3429:Rare diseases 3427: 3425: 3422: 3421: 3419: 3406: 3405: 3398: 3392: 3389: 3387: 3386:BIDS syndrome 3384: 3382: 3379: 3377: 3374: 3372: 3369: 3367: 3364: 3362: 3359: 3357: 3354: 3352: 3349: 3347: 3344: 3342: 3339: 3337: 3334: 3333: 3331: 3327: 3321: 3318: 3316: 3313: 3312: 3310: 3308: 3304: 3294: 3291: 3289: 3286: 3284: 3281: 3280: 3278: 3276: 3272: 3266: 3263: 3261: 3258: 3256: 3253: 3252: 3250: 3248: 3244: 3241: 3239: 3235: 3231: 3224: 3219: 3217: 3212: 3210: 3205: 3204: 3201: 3185: 3182: 3180: 3177: 3175: 3172: 3168: 3164: 3161: 3159: 3156: 3154: 3151: 3150: 3149: 3148: 3147:RecQ helicase 3144: 3143: 3141: 3137: 3131: 3128: 3126: 3123: 3122: 3120: 3118: 3114: 3108: 3105: 3103: 3100: 3098: 3095: 3094: 3092: 3090: 3086: 3082: 3076: 3073: 3069: 3066: 3065: 3064: 3063:Thymine dimer 3061: 3059: 3055: 3052: 3051: 3049: 3047: 3043: 3040: 3038: 3034: 3026: 3023: 3022: 3021: 3020: 3015: 3011: 3010: 3005: 3002: 3001: 3000: 2999: 2994: 2993: 2991: 2989: 2985: 2981: 2977: 2973: 2966: 2961: 2959: 2954: 2952: 2947: 2946: 2943: 2929: 2926: 2925: 2923: 2920: 2916: 2915: 2911: 2908: 2904: 2903: 2899: 2896: 2892: 2888: 2887: 2883: 2880: 2876: 2872: 2871: 2867: 2864: 2860: 2859: 2855: 2851: 2848: 2844: 2843: 2839: 2836: 2832: 2831: 2827: 2826: 2824: 2818: 2812: 2809: 2807: 2804: 2803: 2801: 2797: 2791: 2788: 2786: 2783: 2781: 2778: 2776: 2773: 2771: 2768: 2766: 2763: 2761: 2758: 2756: 2753: 2751: 2748: 2746: 2743: 2742: 2740: 2738: 2734: 2726: 2723: 2721: 2718: 2716: 2713: 2711: 2708: 2707: 2705: 2701: 2698: 2696: 2693: 2691: 2688: 2686: 2683: 2681: 2678: 2676: 2673: 2672: 2670: 2668: 2664: 2658: 2655: 2653: 2650: 2648: 2645: 2643: 2640: 2638: 2635: 2633: 2630: 2628: 2625: 2623: 2620: 2618: 2615: 2613: 2610: 2608: 2605: 2603: 2600: 2599: 2597: 2595: 2594:Short stature 2591: 2583: 2580: 2578: 2575: 2573: 2570: 2568: 2565: 2563: 2560: 2559: 2557: 2553: 2550: 2548: 2545: 2543: 2540: 2538: 2535: 2533: 2530: 2528: 2525: 2524: 2523: 2520: 2519: 2517: 2515: 2511: 2506: 2499: 2494: 2492: 2487: 2485: 2480: 2479: 2476: 2463: 2459: 2458: 2454: 2452: 2448: 2447: 2443: 2441: 2437: 2436: 2432: 2431: 2428: 2424: 2417: 2413: 2412: 2408: 2406: 2402: 2401: 2397: 2395: 2391: 2390: 2386: 2384: 2381: 2378: 2374: 2373: 2369: 2367: 2363: 2362: 2358: 2354: 2351: 2347: 2343: 2342: 2338: 2334: 2333: 2330: 2325: 2321: 2315: 2314: 2309: 2308: 2295: 2289: 2281: 2277: 2273: 2269: 2265: 2261: 2257: 2253: 2249: 2242: 2234: 2230: 2225: 2220: 2216: 2212: 2208: 2204: 2200: 2193: 2185: 2179: 2165: 2159: 2145: 2141: 2134: 2125: 2119: 2115: 2112: 2106: 2098: 2094: 2089: 2084: 2079: 2074: 2070: 2066: 2062: 2058: 2054: 2047: 2039: 2035: 2030: 2025: 2021: 2017: 2013: 2009: 2005: 1998: 1990: 1986: 1981: 1976: 1972: 1968: 1965:(1): 247–58. 1964: 1960: 1956: 1949: 1941: 1937: 1932: 1927: 1923: 1919: 1915: 1911: 1907: 1900: 1898: 1889: 1885: 1880: 1875: 1871: 1867: 1863: 1859: 1855: 1848: 1846: 1844: 1842: 1840: 1831: 1827: 1822: 1817: 1813: 1809: 1805: 1801: 1797: 1790: 1782: 1778: 1773: 1768: 1764: 1760: 1756: 1752: 1748: 1744: 1740: 1733: 1718: 1714: 1708: 1702: 1697: 1690: 1684: 1675: 1673: 1671: 1669: 1667: 1665: 1657: 1651: 1649: 1647: 1645: 1643: 1641: 1631: 1629: 1627: 1625: 1616: 1612: 1608: 1604: 1600: 1596: 1589: 1587: 1585: 1583: 1574: 1570: 1566: 1562: 1558: 1554: 1547: 1539: 1535: 1531: 1527: 1523: 1519: 1515: 1511: 1507: 1503: 1499: 1492: 1483: 1481: 1479: 1477: 1475: 1466: 1460: 1456: 1451: 1450: 1441: 1433: 1429: 1424: 1419: 1415: 1411: 1407: 1400: 1396: 1385: 1382: 1380: 1377: 1375: 1372: 1370: 1367: 1365: 1362: 1361: 1350: 1348: 1344: 1340: 1336: 1334: 1331: 1330: 1327: 1326:thyroid gland 1323: 1319: 1317: 1313: 1309: 1305: 1301: 1299: 1296: 1295: 1291: 1288: 1284: 1281: 1278: 1277: 1273: 1270: 1266: 1263: 1260: 1259: 1255: 1252: 1250: 1247: 1246: 1242: 1238: 1235: 1233: 1232:Renal failure 1230: 1228: 1225: 1224: 1220: 1217: 1213: 1212:liver enzymes 1209: 1205: 1201: 1198: 1194: 1190: 1186: 1184: 1181: 1180: 1176: 1172: 1168: 1164: 1161: 1157: 1153: 1149: 1147: 1144: 1143: 1139: 1136: 1133: 1130: 1126: 1122: 1118: 1114: 1111: 1108: 1106: 1103: 1102: 1098: 1097:demyelination 1094: 1090: 1086: 1082: 1078: 1074: 1070: 1066: 1062: 1059: 1056: 1052: 1050: 1048: 1044: 1040: 1036: 1033: 1029: 1025: 1020: 1017: 1015: 1012: 1011: 1007: 1003: 999: 998:prototympanum 995: 992: 988: 984: 981:. Atrophy of 980: 976: 972: 968: 965: 961: 958: 954: 952: 948: 945: 944: 941: 939: 935: 932: 928: 927:Hirano bodies 924: 920: 916: 912: 908: 905: 901: 897: 893: 889: 885: 881: 877: 874: 870: 866: 862: 858: 857:malformations 854: 850: 846: 842: 838: 834: 832: 828: 824: 821: 817: 813: 809: 805: 803: 799: 795: 791: 787: 786:basal ganglia 783: 779: 775: 774:Calcification 770: 766: 762: 758: 754: 750: 746: 742: 738: 735: 731: 730:Schwann cells 727: 723: 719: 718:Demyelination 716: 713: 709: 705: 701: 697: 693: 689: 685: 681: 678: 676: 673: 672: 669: 666: 662: 659: 657: 653: 649: 646: 645: 642: 640: 636: 635:Dental caries 632: 630: 627: 626: 622: 619: 616: 615: 612: 603: 594: 591: 581: 577: 568: 566: 562: 558: 548: 540: 532: 529: 519: 517: 513: 509: 505: 501: 497: 493: 489: 485: 481: 471: 469: 465: 460: 458: 455:(rather than 454: 450: 446: 442: 438: 435:), a 5' – 3' 434: 430: 425: 423: 419: 416: 412: 408: 404: 391: 386: 385: 379: 377: 374: 371: 370: 366: 363: 361: 358: 355: 354: 350: 347: 345: 342: 339: 338: 334: 332: 329: 326: 325: 322: 320: 312: 308: 303: 294: 292: 288: 284: 280: 276: 272: 268: 264: 260: 256: 255:developmental 252: 248: 245:, children's 244: 243:transcription 240: 236: 235:free radicals 232: 228: 224: 210: 207: 204: 200: 196: 192: 191: 185: 183: 179: 174: 171: 166: 164: 163: 158: 154: 153: 148: 144: 140: 135: 131: 127: 123: 119: 115: 112: 109: 105: 101: 97: 87: 81: 77: 73: 70: 68: 64: 60: 55: 51: 47: 42: 34: 30: 19: 3401: 3282: 3145: 3053: 3017: 3012:Termination/ 2996: 2912: 2900: 2884: 2868: 2852: 2840: 2828: 2700:Gastrulation 2611: 2514:Craniofacial 2455: 2444: 2433: 2409: 2398: 2387: 2370: 2355: 2335: 2310: 2288: 2255: 2251: 2241: 2206: 2202: 2192: 2178: 2167:. Retrieved 2158: 2147:. Retrieved 2143: 2133: 2124: 2105: 2060: 2056: 2046: 2011: 2007: 1997: 1962: 1958: 1948: 1916:(1): 62–78. 1913: 1910:J. Mol. Biol 1909: 1861: 1857: 1803: 1799: 1789: 1746: 1742: 1732: 1720:. Retrieved 1716: 1707: 1696: 1683: 1601:(1): 68–84. 1598: 1594: 1556: 1552: 1546: 1505: 1501: 1491: 1448: 1440: 1416:(8): 701–5. 1413: 1409: 1399: 1227:Renal system 1208:splenomegaly 1204:Hepatomegaly 1197:percutaneous 1195:. Many have 1152:hypertension 1150:Accelerated 1117:Contractures 1079:atrophy and 1069:perivascular 1043:Enophthalmos 1022: 989:, thickened 960:hearing loss 835: 833:is present. 806: 772: 769:degeneration 737:white matter 680:Microcephaly 609: 600: 597:Epidemiology 587: 578: 574: 554: 546: 538: 525: 480:microcephaly 477: 461: 459:) template. 426: 400: 321:as follows: 316: 220: 175: 167: 160: 156: 150: 146: 143:white matter 103: 99: 95: 94: 3117:MRN complex 2822:known locus 2720:Sirenomelia 2446:GeneReviews 1210:, elevated 1191:. Abnormal 1135:Denervation 1093:Optic nerve 1081:hyperplasia 911:Ventricular 886:, granular 847:, multiple 820:accelerated 802:capillaries 749:spinal cord 543:Other Tests 437:exonuclease 415:transcribed 380:none known 319:genetically 311:inheritance 309:pattern of 80:dermatology 49:Other names 3418:Categories 3402:See also: 3238:DNA repair 3037:DNA repair 3014:telomerase 2715:Ectromelia 2400:DiseasesDB 2169:2023-07-06 2149:2023-07-06 1391:References 1337:Decreased 1269:testicular 1267:, smaller 1265:Micropenis 1216:metabolism 1214:. Altered 1165:Increased 1077:epithelial 1065:Lipofuscin 1039:Optic disk 996:, widened 975:basal turn 934:reactivity 882:. Loss of 837:Astrocytes 810:changes - 798:arterioles 763:. Loss of 761:cerebellum 623:pathology 565:cerebellum 464:DNA repair 429:DNA damage 424:(TC-NER). 275:human cell 267:metabolism 225:or excess 199:congenital 170:DNA repair 155:gene, and 3307:Lamin A/C 2924:Multiple 2507:syndromes 2435:eMedicine 2411:SNOMED CT 1763:1415-4757 1522:1872-6216 1306:. Normal 1287:pregnancy 1125:scoliosis 1110:Cachectic 1045:, Narrow 1024:Cataracts 957:high tone 931:ubiquitin 907:torpedoes 896:Dendrites 876:occipital 869:neocortex 853:FLAIR MRI 845:cytoplasm 841:microglia 818:vessels, 745:brainstem 590:prognosis 584:Prognosis 571:Treatment 561:forebrain 551:Neurology 508:Nystagmus 474:Diagnosis 397:Mechanism 291:apoptosis 263:molecular 223:hyperoxia 111:recessive 108:autosomal 76:neurology 67:Specialty 2998:RNASEH2A 2704:mesoderm 2567:Cyclopia 2457:Orphanet 2416:21086008 2352:Q87.110) 2272:25851792 2233:27507608 2209:: 3–17. 2114:Archived 2097:26100862 2038:25820262 1989:25505141 1940:26616585 1888:27507608 1864:: 3–17. 1781:32453336 1573:19812404 1538:19137836 1530:23428416 1432:16865293 1358:See also 1218:of drugs 1138:myopathy 1121:Kyphosis 1113:dwarfism 1085:ganglion 1075:pigment 1061:granules 1041:pallor, 940:present 915:cisterna 884:Purkinje 873:parietal 808:Vascular 794:arteries 790:thalamus 757:Neuronal 734:cerebral 724:". Both 704:seizures 496:cachetic 492:kyphosis 484:dwarfism 449:G1 phase 297:Genetics 251:proteins 122:sunlight 2440:ped/424 2394:D003057 2280:5311897 2224:5195851 2088:4500203 2065:Bibcode 2029:4491999 1980:4288174 1931:4738086 1879:5195851 1830:8290349 1772:7250278 1615:1308368 1320:Normal 1283:Ovarian 1279:Females 1187:Severe 1073:Retinal 1058:pigment 1055:melanin 971:cochlea 947:Hearing 888:neurons 880:atrophy 831:Gliosis 776:of the 708:strokes 696:Tremors 667:access. 557:putamen 433:DCLRE1A 279:lesions 247:genetic 29:cocaine 2558:Other 2383:216411 2380:133540 2377:216400 2278:  2270:  2231:  2221:  2095:  2085:  2036:  2026:  2008:EMBO J 1987:  1977:  1938:  1928:  1886:  1876:  1828:  1821:310470 1818:  1779:  1769:  1761:  1722:7 July 1613:  1571:  1536:  1528:  1520:  1461:  1430:  1347:saliva 1189:reflux 1167:intima 1035:pupils 1032:Miotic 1014:Vision 994:curare 991:stapes 904:axonal 849:nuclei 800:, and 751:, and 710:, and 700:ataxia 688:low IQ 665:venous 376:216411 360:133540 344:216400 287:genome 227:oxygen 217:Causes 165:gene. 82:  3139:Other 2667:Limbs 2366:759.8 2346:Q87.1 2276:S2CID 1534:S2CID 1343:tears 1261:Males 938:axons 865:sulci 861:gyral 782:sulci 686:with 656:nails 466:(see 418:genes 365:ERCC6 349:ERCC8 335:Gene 327:Type 259:blood 188:Types 162:ERCC6 152:ERCC8 3019:DKC1 2978:and 2405:2907 2389:MeSH 2372:OMIM 2361:9-CM 2350:ILDS 2268:PMID 2229:PMID 2093:PMID 2034:PMID 1985:PMID 1936:PMID 1884:PMID 1826:PMID 1777:PMID 1759:ISSN 1724:2021 1611:PMID 1569:PMID 1526:PMID 1518:ISSN 1459:ISBN 1428:PMID 1324:and 1271:size 949:and 839:and 825:and 728:and 652:hair 648:Skin 629:Face 588:The 405:and 331:OMIM 3085:MSI 2462:191 2357:ICD 2337:ICD 2260:doi 2219:PMC 2211:doi 2083:PMC 2073:doi 2061:112 2024:PMC 2016:doi 1975:PMC 1967:doi 1926:PMC 1918:doi 1914:428 1874:PMC 1866:doi 1816:PMC 1808:doi 1767:PMC 1751:doi 1603:doi 1561:doi 1557:361 1510:doi 1506:134 1455:575 1418:doi 936:of 898:of 804:). 470:). 457:DNA 453:RNA 407:CSB 403:CSA 293:). 239:DNA 221:If 3420:: 3016:: 2974:: 2914:19 2902:15 2893:, 2886:12 2877:, 2858:13 2706:: 2460:: 2449:: 2438:: 2414:: 2403:: 2392:: 2375:: 2364:: 2344:: 2341:10 2274:. 2266:. 2256:57 2254:. 2250:. 2227:. 2217:. 2207:33 2205:. 2201:. 2142:. 2091:. 2081:. 2071:. 2059:. 2055:. 2032:. 2022:. 2012:34 2010:. 2006:. 1983:. 1973:. 1963:43 1961:. 1957:. 1934:. 1924:. 1912:. 1908:. 1896:^ 1882:. 1872:. 1862:33 1860:. 1856:. 1838:^ 1824:. 1814:. 1804:21 1802:. 1798:. 1775:. 1765:. 1757:. 1747:43 1745:. 1741:. 1715:. 1663:^ 1639:^ 1623:^ 1609:. 1599:42 1597:. 1581:^ 1567:. 1555:. 1532:. 1524:. 1516:. 1504:. 1500:. 1473:^ 1457:. 1426:. 1414:51 1412:. 1408:. 1351:- 1345:, 1341:, 1314:, 1310:, 1292:- 1274:- 1256:- 1243:. 1221:- 1206:, 1202:. 1177:. 1173:, 1162:. 1158:. 1154:. 1123:, 1119:. 1115:. 1063:. 1049:. 1037:, 1021:. 985:. 925:, 921:, 894:. 829:. 796:, 784:, 771:. 755:. 747:, 743:, 739:, 714:. 706:, 702:, 698:, 690:. 654:, 650:, 637:, 445:G0 372:C 356:B 340:A 132:. 100:CS 78:, 74:, 3222:e 3215:t 3208:v 3165:/ 3087:/ 3056:/ 2964:e 2957:t 2950:v 2921:) 2917:( 2909:) 2905:( 2897:) 2889:( 2881:) 2873:( 2870:8 2865:) 2861:( 2856:/ 2854:4 2849:) 2845:( 2842:3 2837:) 2833:( 2830:2 2702:/ 2497:e 2490:t 2483:v 2359:- 2348:( 2339:- 2329:D 2296:. 2282:. 2262:: 2235:. 2213:: 2186:. 2172:. 2152:. 2099:. 2075:: 2067:: 2040:. 2018:: 1991:. 1969:: 1942:. 1920:: 1890:. 1868:: 1832:. 1810:: 1783:. 1753:: 1726:. 1617:. 1605:: 1575:. 1563:: 1540:. 1512:: 1467:. 1434:. 1420:: 1253:- 1131:. 694:. 447:/ 313:. 124:( 98:( 35:. 20:)

Index

Cerebrooculofacioskeletal syndrome
cocaine
Cockayne (disambiguation)

Specialty
Medical genetics
neurology
dermatology
Edit this on Wikidata
autosomal
recessive
neurodegenerative
nervous system
sunlight
photosensitivity
premature aging
Failure to thrive
leukodystrophies
white matter
ERCC8
ERCC6
DNA repair
Edward Alfred Cockayne
Hutchinson–Gilford progeria syndrome
congenital
xeroderma pigmentosum
hyperoxia
oxygen
cellular metabolism
free radicals

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑